middle.news

Viatris completes Pacira deal and expands non-opioid pain portfolio

1:44am on Wednesday 18th of November, 2026 AEDT • Pharmaceuticals
Read Story

Viatris completes Pacira deal and expands non-opioid pain portfolio

1:44am on Wednesday 18th of November, 2026 AEDT
Key Points
  • US$1.69 billion acquisition completed with cash and short-term borrowings
  • 66.46% of Pacira shares were validly tendered
  • Pacira becomes a wholly owned Viatris subsidiary
  • US$90 million to US$100 million expected 2026 revenue contribution
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Viatris (NASDAQ:VTRS)
OPEN ARTICLE